Critically, subsequent research demonstrated that miR-32-3p downregulates PLA2G4A (phospholipase A2, group IVA) expression, and this interaction impacts glucose metabolism in PCOS patients (55). Here, PLA2G4A is linked to polycystic ovary syndrome.